Business: Healthcare & Pharmaceuticals
Two and a half cheers for Bill Gates
To tackle neglected tropical diseases we need a far more collaborative and flexible approach.
Atos is "black and white" on fitness and disability
One man's experience of successfully appealing a Work Capability Assessment ruling.
Could pseudo-science fund cancer research?
The geeks are on the march with increasingly vocal and co-ordinated calls for an end to crystal healing and the rest.
The precarity of the global 99%
What The Global Fund's decision to cancel next year's funding round means for victims of Aids, TB and malaria.
Google fined $500m for illegal advertising
The US-based multinational corporation was profiting from the illegal sale of drugs from Canada.
GMC pushes ahead with secret doctors' courts plan
Plans to hold some misconduct hearings in private look set to go ahead.
AFFiRiS to get MJFF grant for Parkinson's vaccine
Foundation will now support the development of the PD01 vaccine by AFFiRiS with $475,000
ACCC not to oppose Sigma acquisition of Aspen
ISTA Pharma starts Phase 2 Bepotastine besilate nasal spray study
Novartis signs merger agreement with Alcon
Pharmasset commences dosing in PSI-7977 trial
Bayer HealthCare to build biologicals facility in Wuppertal, Germany
PAR, Experian enters into B2B data sharing partnership
Jeffrey Kindler steps down as CEO of Pfizer
Defense Intelligence Agency awards five-year SITE contract to CenTauri
GSK to invest £500m and create 1000 jobs after UK tax changes
Osborne's failure
Knighthood row
Don't be fooled
The tide turns
Cameron is vague
Here to stay?
Misleading report
Defends Euro
Enter search term below: Policy | Charity & Fundraising | Research | Education | Executive | Media | Social Care | Communications
Newsletter!
Enter your email address here to receive updates from the team
Can the UK achieve it’s commitment to carbon reduction targets by 2020?
